A TIMELESS ODYSSEY
WE ARE CULTIVATING EXCELLENCE OVER THE DECADES
Starting a journey tied to our history, our story is all about sticking to being excellent and always moving forward. We began small but achieved big things, blending old ways with new dreams. With lots of successes, we respect where we came from and look forward to breaking limits and creating what's next. Our story isn't just a look back; it's proof that we keep going strong. Get ready for a story that's both classic and looking ahead!
Drug International Limited was founded in 1974, marking the beginning of a journey dedicated to pharmaceutical excellence. The company was incorporated under the Registrar of Joint Stock Companies as a Private Limited Company.
Drug International Limited embarked on the formulation and production journey in 1980, laying the groundwork for becoming a pioneer in pharmaceutical manufacturing in Bangladesh.
The year 1985 witnessed a significant milestone with the establishment of a state-of-the-art oral solid dosage plant, solidifying the company's commitment to quality pharmaceuticals.
Drug International Limited achieved a breakthrough in 1990 by becoming the first company in Bangladesh to formulate medicines in soft gelatin capsule form, optimizing absorption and retention properties.
In 1995, the company introduced GYNOMIX, a soft gelatin capsule vaginal suppository with anti-bacterial and anti-fungal properties, showcasing innovation in women's healthcare.
In 1995, the company introduced GYNOMIX, a soft gelatin capsule vaginal suppository with anti-bacterial and anti-fungal properties, showcasing innovation in women's healthcare.
Drug International Limited expanded its global footprint in 2000 by exporting pharmaceutical products to numerous countries, contributing to the company's international recognition.
The adoption of unique supply chain management principles in 2005 became a hallmark for Drug International Limited, ensuring optimized versions of medicines and immediate market release.
Drug International Limited reinforced its commitment to patient welfare in 2010, aligning formulating principles to enhance the quality of life for patients and customers.
In 2024, Drug International Limited continues its legacy of excellence, utilizing refined production processes to export pharmaceutical products worldwide, contributing to the well-being of communities globally.
Drug International Limited was founded in 1974, marking the beginning of a journey dedicated to pharmaceutical excellence. The company was incorporated under the Registrar of Joint Stock Companies as a Private Limited Company.
Drug International Limited embarked on the formulation and production journey in 1980, laying the groundwork for becoming a pioneer in pharmaceutical manufacturing in Bangladesh.
The year 1985 witnessed a significant milestone with the establishment of a state-of-the-art oral solid dosage plant, solidifying the company's commitment to quality pharmaceuticals.
Drug International Limited achieved a breakthrough in 1990 by becoming the first company in Bangladesh to formulate medicines in soft gelatin capsule form, optimizing absorption and retention properties.
In 1995, the company introduced GYNOMIX, a soft gelatin capsule vaginal suppository with anti-bacterial and anti-fungal properties, showcasing innovation in women's healthcare.
In 1995, the company introduced GYNOMIX, a soft gelatin capsule vaginal suppository with anti-bacterial and anti-fungal properties, showcasing innovation in women's healthcare.
Drug International Limited expanded its global footprint in 2000 by exporting pharmaceutical products to numerous countries, contributing to the company's international recognition.
The adoption of unique supply chain management principles in 2005 became a hallmark for Drug International Limited, ensuring optimized versions of medicines and immediate market release.
Drug International Limited reinforced its commitment to patient welfare in 2010, aligning formulating principles to enhance the quality of life for patients and customers.
In 2024, Drug International Limited continues its legacy of excellence, utilizing refined production processes to export pharmaceutical products worldwide, contributing to the well-being of communities globally.